Tolerx, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company is focused on discovering and developing new therapies designed to treat patients by reprogramming the immune system, allowing for long-term remission of immune-related diseases after a short course of therapy. Targeted diseases include type 1 diabetes, rheumatoid arthritis, Inflammatory bowel disease (IBD), cancer, chronic and viral diseases.

PropertyValue
dbpedia-owl:Company/industry
dbpedia-owl:Organisation/foundationDate
  • 2000-01-01 00:00:00 (xsd:date)
dbpedia-owl:Organisation/location
dbpedia-owl:foundationDate
  • 2000-01-01 00:00:00 (xsd:date)
dbpedia-owl:industry
dbpedia-owl:location
dbpprop:abstract
  • Tolerx, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company is focused on discovering and developing new therapies designed to treat patients by reprogramming the immune system, allowing for long-term remission of immune-related diseases after a short course of therapy. Targeted diseases include type 1 diabetes, rheumatoid arthritis, Inflammatory bowel disease (IBD), cancer, chronic and viral diseases. In 2008, Tolerx was named one of Fierce Biotech’s Fierce 15.
dbpprop:companyLogo
dbpprop:companyName
  • Tolerx, Inc.
dbpprop:companyType
  • Private
dbpprop:foundation
  • 2000 (xsd:integer)
dbpprop:homepage
dbpprop:industry
dbpprop:location
dbpprop:reference
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Tolerx, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company is focused on discovering and developing new therapies designed to treat patients by reprogramming the immune system, allowing for long-term remission of immune-related diseases after a short course of therapy. Targeted diseases include type 1 diabetes, rheumatoid arthritis, Inflammatory bowel disease (IBD), cancer, chronic and viral diseases.
rdfs:label
  • Tolerx
skos:subject
foaf:homepage
foaf:name
  • Tolerx, Inc.
foaf:page
is dbpprop:redirect of